Abstract
During normal pregnancy, the concentrations of many of the clotting factors rise, thereby increasing the potential to generate fibrin. There is also evidence of increased thrombin activity during normal pregnancy which sharply increases during placental separation. Antithrombin III, the main inhibitor of thrombin and activated factor X, shows no compensatory rise during pregnancy but increases during the puerperium. Plasminogen and antiplasmin concentrations rise during pregnancy but systemic fibrinolytic activity, as measured by the euglobulin lysis time, is markedly depressed during pregnancy; the reduced fibrinolytic activity returns to non-pregnant values very soon after delivery. The loss of fibrinolytic activity is presumed to be loss of plasminogen activator, because when this is added in excess in the urokinase sensitivity test, the fibrinolytic response is normal. The capacity for localized fibrinolytic activity is not lost, however, because fibrinolytic degradation products are slightly raised during pregnancy. The overall pattern is one of increased coagulant and reduced fibrinolytic capacity during pregnancy which may protect the pregnant woman against the haemostatic challenge of placental separation.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Astedt B. Significance of placenta in depression of fibrinolytic activity during pregnancy. J Obstet Gynaecol Br Commonw. 1972 Mar;79(3):205–206. doi: 10.1111/j.1471-0528.1972.tb15783.x. [DOI] [PubMed] [Google Scholar]
- Bonnar J., McNicol G. P., Douglas A. S. Coagulation and fibrinolytic mechanisms during and after normal childbirth. Br Med J. 1970 Apr 25;2(5703):200–203. doi: 10.1136/bmj.2.5703.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bonnar J., McNicol G. P., Douglas A. S. Fibrinolytic enzyme system and pregnancy. Br Med J. 1969 Aug 16;3(5667):387–389. doi: 10.1136/bmj.3.5667.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Condie R. G., Ogston D. Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of pre-eclampsia. Br J Obstet Gynaecol. 1976 Dec;83(12):938–942. doi: 10.1111/j.1471-0528.1976.tb00779.x. [DOI] [PubMed] [Google Scholar]
- EGEBERG O. INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA. Thromb Diath Haemorrh. 1965 Jun 15;13:516–530. [PubMed] [Google Scholar]
- Howie P. W., Evans K., Forbes C. D., Prentice C. R. The effects of stilboestrol and quinestrol upon coagulation and fibrinolysis during the puerperium. Br J Obstet Gynaecol. 1975 Dec;82(12):968–975. doi: 10.1111/j.1471-0528.1975.tb00607.x. [DOI] [PubMed] [Google Scholar]
- Howie P. W., Prentice C. R., McNicol G. P. Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency. J Obstet Gynaecol Br Commonw. 1971 Nov;78(11):992–1003. doi: 10.1111/j.1471-0528.1971.tb00216.x. [DOI] [PubMed] [Google Scholar]
- McKillop C., Forbes C. D., Howie P. W., Prentice C. M. Soluble fibrinogen/fibrin complexes in pre-eclampsia. Lancet. 1976 Jan 10;1(7950):56–58. doi: 10.1016/s0140-6736(76)90150-1. [DOI] [PubMed] [Google Scholar]
- Shaper A. G., Macintosh D. M., Kyobe J. Fibrinolytic activity in pregnancy, during parturition, and in the puerperium. Lancet. 1966 Oct 22;2(7469):874–876. doi: 10.1016/s0140-6736(66)91976-3. [DOI] [PubMed] [Google Scholar]
- TODD M. E., THOMPSON J. H., Jr, BOWIE E. J., OWEN C. A., Jr CHANGES IN BLOOD COAGULATION DURING PREGNANCY. Mayo Clin Proc. 1965 May;40:370–383. [PubMed] [Google Scholar]
- Thornton C. A., Bonnar J. Factor VIII-related antigen and factor VIII coagulant activity in normal and pre-eclamptic pregnancy. Br J Obstet Gynaecol. 1977 Dec;84(12):919–923. doi: 10.1111/j.1471-0528.1977.tb12521.x. [DOI] [PubMed] [Google Scholar]
- Wallenburg H. C., van Kessel P. H. Platelet lifespan in normal pregnancy as determined by a nonradioisotopic technique. Br J Obstet Gynaecol. 1978 Jan;85(1):33–36. doi: 10.1111/j.1471-0528.1978.tb15821.x. [DOI] [PubMed] [Google Scholar]
- Whigham K. A., Howie P. W., Drummond A. H., Prentice C. R. Abnormal platelet function in pre-eclampsia. Br J Obstet Gynaecol. 1978 Jan;85(1):28–32. doi: 10.1111/j.1471-0528.1978.tb15820.x. [DOI] [PubMed] [Google Scholar]
- Woodfield D. G., Cole S. K., Allan A. G., Cash J. D. Serum fibrin degradation products throughout normal pregnancy. Br Med J. 1968 Dec 14;4(5632):665–668. doi: 10.1136/bmj.4.5632.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Royen E. A., ten Cate J. W. Antigen biological activity ratio for factor VIII in late pregnancy. Lancet. 1973 Aug 25;2(7826):449–450. doi: 10.1016/s0140-6736(73)92320-9. [DOI] [PubMed] [Google Scholar]